Status:
COMPLETED
Improving Prescription Drug Warning Labels
Lead Sponsor:
Northwestern University
Collaborating Sponsors:
Louisiana State University Health Sciences Center Shreveport
Emory University
Conditions:
Enhanced Text
Enhanced Text + Icon
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
Prior studies have documented a high prevalence of patients misunderstanding prescription drug warning labels, placing them at risk for medication error. We sought to evaluate the effectiveness of 'e...
Detailed Description
Adult patients attending one of four outpatient primary care clinics were recruited in two distinct cities (Shreveport, Louisiana; Chicago, Illinois). One clinic in each city was a general medicine ac...
Eligibility Criteria
Inclusion
- \> 18 years old
Exclusion
- cognitive impairment
- vision or hearing impairment
- non-English speaking
- severely ill
Key Trial Info
Start Date :
June 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2009
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT00846209
Start Date
June 1 2007
End Date
February 1 2009
Last Update
November 14 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Northwestern Memorial Faculty Foundation
Chicago, Illinois, United States, 60611